Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Puma Biotechnology (PBYI) Equity Ratio (2017 - 2025)

Historic Equity Ratio for Puma Biotechnology (PBYI) over the last 9 years, with Q3 2025 value amounting to 0.57.

  • Puma Biotechnology's Equity Ratio rose 7642.31% to 0.57 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.57, marking a year-over-year increase of 7642.31%. This contributed to the annual value of 0.43 for FY2024, which is 8627.75% up from last year.
  • Per Puma Biotechnology's latest filing, its Equity Ratio stood at 0.57 for Q3 2025, which was up 7642.31% from 0.54 recorded in Q2 2025.
  • Puma Biotechnology's 5-year Equity Ratio high stood at 0.57 for Q3 2025, and its period low was 0.05 during Q3 2021.
  • Over the past 5 years, Puma Biotechnology's median Equity Ratio value was 0.15 (recorded in 2023), while the average stood at 0.21.
  • Its Equity Ratio has fluctuated over the past 5 years, first tumbled by 268830.19% in 2021, then soared by 100140.69% in 2022.
  • Over the past 5 years, Puma Biotechnology's Equity Ratio (Quarter) stood at 0.01 in 2021, then soared by 1001.41% to 0.1 in 2022, then surged by 138.24% to 0.23 in 2023, then surged by 86.28% to 0.43 in 2024, then soared by 31.58% to 0.57 in 2025.
  • Its last three reported values are 0.57 in Q3 2025, 0.54 for Q2 2025, and 0.49 during Q1 2025.